Point-of-care technology market seen reaching $67.94B by 2030

The point-of-care technology market is projected to grow from $47.41 billion in 2026 to $67.94 billion by 2030, according to The Business Research Company. Demand is rising as healthcare systems push faster diagnostics at hospitals, clinics, homes and remote settings.

Why it matters: - Point-of-care tools help clinicians get diagnostic results near the patient instead of waiting on centralized labs. - Faster testing can speed treatment decisions, improve monitoring for chronic disease and support care in rural or remote settings. - The market’s forecast growth points to continued demand for decentralized and home-based healthcare delivery.

What happened: - The Business Research Company published its Point-of-Care Technology Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report estimates the market rose from $43.21 billion in 2025 to $47.41 billion in 2026. - The report projects the market will reach $67.94 billion by 2030. - The report says the market is growing at a 9.7% CAGR from 2025 to 2026 and a 9.4% CAGR through 2030.

The details: - Point-of-care technology includes medical diagnostic tools and devices used near the site of patient care, including hospitals, clinics and patients’ homes. - These tools deliver quick, accurate and real-time diagnostic results. - The technology reduces reliance on centralized laboratory testing. - The report links historical growth to centralized lab dependence, limited rapid diagnostics in rural and remote regions, higher infectious disease prevalence, increased hospital patient volumes and early adoption of basic point-of-care devices. - The report identifies microfluidics and PCR technologies as key enablers of future growth. - The report also points to rising chronic and lifestyle diseases, expansion of homecare and decentralized care models, greater digitization of healthcare and favorable regulation for rapid diagnostics. - The report highlights rising demand for rapid testing at the point of care, more home-based and remote testing, more portable and handheld diagnostics, broader infectious and chronic disease testing, and easier-to-use tests with faster turnaround times. - North America held the largest market share in 2025. - Asia-Pacific is expected to grow the fastest خلال the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report includes new analytical features such as market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables. - A free sample of the report is available here. - The full report is available here.

Between the lines: - The biggest growth driver is not just better devices; it is the broader shift toward faster, more distributed care. - Chronic disease management is becoming a bigger use case as more patients need frequent testing outside traditional labs. - The NHS data cited in the release shows the pressure on diagnostic systems is already rising: 3,615,330 people registered with general practitioners were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, up 18% from 3,065,825 in 2022. - The regional split suggests mature markets still lead in size, while infrastructure investment is opening faster growth in Asia-Pacific.

What's next: - The report expects technology advances and healthcare decentralization to keep expanding demand through 2030. - Market competition is likely to focus on faster turnaround, portability, home use and broader disease coverage. - The Business Research Company is offering a free sample and the full report to interested buyers and analysts.

The bottom line: - Point-of-care technology is moving from a convenience category to a core part of modern diagnostics, with global revenue set to climb steadily through the end of the decade.